HIV status alters disease severity and immune cell responses in beta variant sars-COV-2 infection wave

31Citations
Citations of this article
72Readers
Mendeley users who have this article in their library.
Get full text

Abstract

There are conicting reports on the effects of HIV on COVID-19. Here we analyzed disease severity and immune cell changes during and after SARS-CoV-2 infection in participants from South Africa, of which 39% were people living with HIV (PLWH), during the first and second (beta dominated) infection waves. The second wave had more PLWH requiring supplemental oxygen relative to HIV negative participants. Higher disease severity was associated with low CD4 T cell counts and higher neutrophil to lymphocyte ratios (NLR). Yet, CD4 counts recovered and NLR stabilized after SARS-CoV-2 clearance in wave 2 infected PLWH, arguing for an interaction between SARS-CoV-2 and HIV infection leading to low CD4 and high NLR. The first infection wave, where severity in HIV negative and PLWH was similar, still showed some HIV modulation of SARS-CoV-2 immune responses. Therefore, HIV infection can synergize with the SARS-CoV-2 variant to change COVID-19 outcomes.

Cite

CITATION STYLE

APA

Karim, F., Gazy, I., Cele, S., Zungu, Y., Krause, R., Bernstein, M., … Sigal, A. (2021). HIV status alters disease severity and immune cell responses in beta variant sars-COV-2 infection wave. ELife, 10. https://doi.org/10.7554/eLife.67397

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free